Booking (BKNG) is expected to have a weak 2021, but
COVID-19 vaccines are now being distributed. So travel looks to surge surge in 2021, and Booking (BKNG) should thrive.
Booking.com (BKNG), formerly Priceline, might not have profits return to normal until 2022. Time to sell the stock?
Travel isn’t bouncing back anytime soon, and that’s bad for Booking Holdings (BKNG). Still, long-term upside is solid.
Booking (BKNG) is down-and-out as travel plans have been zapped worldwide. But there’s 70% upside to our 2021 Fair Value.
Booking (BKNG), formerly Priceline, delivers a perfect blend of safety and growth for both conservative and growth investors.
Booking (BKNG) grew profits 15% last qtr even though a strong U.S. dollar trimmed sales growth from 12% to 7%.
Booking.com (BKNG) has a lot of little things bringing down profits last qtr. Should we be concerned or will profits bounce back?
Booking (BKNG) management is spending to grow its brand, and will incur some currency expenses, which will hut profits. But BKNG always underpromises.
Although it doesn’t grow as fast as it used to, Booking (BKNG) has still increased every since year since 2003. Now that it’s dipped, BKND is lookin good for 2019.
The word-on-the-street Booking’s (BKNG) growth was slowing. Apparently not. BKNG delivered 37% profit growth last qtr.
Booking (BKNG) has been growing like a weed the last decade, yet even at this large scale was still able to deliver 21% profit growth last qtr.
Priceline (PCLN) has changed its company name to Booking Holdings (BKNG) as Booking.com drives a significant majority of operating results.